Literature DB >> 18551263

[Therapy of herpes zoster].

A J Ullmann1.   

Abstract

Mesh：

Year:  2008        PMID： 18551263     DOI： 10.1007/s00108-008-2174-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  35 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

2.  A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group.

Authors:  P Ljungman; B Lönnqvist; O Ringdén; P Skinhöj; G Gahrton
Journal:  Bone Marrow Transplant       Date:  1989-11       Impact factor: 5.483

3.  Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).

Authors:  M Sandherr; H Einsele; H Hebart; C Kahl; W Kern; M Kiehl; G Massenkeil; O Penack; X Schiel; S Schuettrumpf; A J Ullmann; O A Cornely
Journal:  Ann Oncol       Date:  2006-01-12       Impact factor: 32.976

4.  Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy.

Authors:  G Breton; A M Fillet; C Katlama; F Bricaire; E Caumes
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

Review 5.  Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.

Authors:  K M Sullivan; C A Dykewicz; D L Longworth; M Boeckh; L R Baden; R H Rubin; K A Sepkowitz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

6.  A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.

Authors:  S Tyring; R Belanger; W Bezwoda; P Ljungman; R Boon; R L Saltzman
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

7.  Progressive outer retinal necrosis syndrome: a comprehensive review of its clinical presentation, relationship to immune system status, and management.

Authors: 
Journal:  Clin Eye Vis Care       Date:  2000-12

8.  Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy).

Authors:  P Morgan-Capner; N S Crowcroft
Journal:  Commun Dis Public Health       Date:  2002-03

9.  Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.

Authors:  Stephen D Shafran; Stephen K Tyring; Richard Ashton; Jacque Decroix; Chistine Forszpaniak; Alan Wade; Christian Paulet; Daniel Candaele
Journal:  J Clin Virol       Date:  2004-04       Impact factor: 3.168

10.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.